PATRICIA MORALES: Open Payments
NPI 1033465166 · SALISBURY, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$799 in 30 payments from 11 companies in 2025. Trend: 2023 $2,110 · 2024 $1,216 · 2025 $799
Food & beverage: $795Education: $4
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 10 | $375 |
| Axsome Therapeutics, Inc. | 4 | $95 |
| Novo Nordisk Inc | 4 | $65 |
| Lilly USA, LLC | 3 | $54 |
| Amgen Inc. | 2 | $52 |
| Phathom Pharmaceuticals, Inc. | 2 | $49 |
| BETA BIONICS, INC. | 1 | $39 |
| Alexion Pharmaceuticals, Inc. | 1 | $20 |
| ABBVIE INC. | 1 | $17 |
| Exact Sciences Corporation | 1 | $17 |
Products named: Korlym, Symbravo, MOUNJARO, VOQUEZNA, iLet Bionic Pancreas, TEPEZZA, Rybelsus, EVENITY.
Industry payments across MD — which companies pay providers there.
